Inventor · disambiguated record
Daniel Fass
Also filed as: FASS DANIEL
1 granted patent·8 pending applications·3 citations·filing 2009–2015
22Inventor score
Files withMOON RANDALL T3UNIV WASHINGTON2GEN HOSPITAL CORP1HAGGARTY STEPHEN J1MASSACHUSETTS INST TECHNOLOGY1
Top patents by PatentIndex Score
9 records- 0172US9265764B2Uses of chemicals to modulate GSK-3 signaling for treatment of bipolar disorder and other brain disordersHAGGARTY STEPHEN J·Filed 2010·Granted Feb 23, 2016·3 cites·18 claims
- 0263US2012046242A1Molecular activators of the wnt/beta-catenin pathwayMOON RANDALL T·Filed 2009·Application pending·0 cites
- 0355US2012040916A1Molecular inhibitors of the wnt/beta-catenin pathwayMOON RANDALL T·Filed 2009·Application pending·0 cites
- 0454US2011200686A1Compositions of modulators of the wnt/b-catenin pathway and an n-cinnamyl-n'benzhydryl piperazine and their use in treating neoplastic conditions including malignant melanomaUNIV OG WASHINGTON·Filed 2009·Application pending·0 cites
- 0554US2011251144A1Molecular modulators of the wnt/beta-catenin pathwayMASSACHUSETTS INST TECHNOLOGY·Filed 2009·Application pending·0 cites
- 0651US2013039998A1Compositions of modulators of the wnt/beta-catenin pathway and benzamide and/or hydroxamic acid derivatives to treat bipolar disorderUNIV WASHINGTON·Filed 2009·Application pending·0 cites
- 0745US2014080775A1Molecular modulators of the wnt/beta-catenin pathwayUNIV WASHINGTON·Filed 2013·Application pending·0 cites
- 0842US2017049793A1Molecular activators of the wnt/beta-catenin pathwayMOON RANDALL T·Filed 2015·Application pending·0 cites
- 0940US2014187510A1Molecular activators of the wnt/beta-catenin pathwayGEN HOSPITAL CORP·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel Fass files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →